Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Urology
Literature
1.
Lee KS, Koo KC, Chung BH (2018) Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study. World J Urol 36(7):1059–1106CrossRef
2.
Cyll K, Ersvær E, Vlatkovic L, Pradhan M, Kildal W, Avranden Kjær M, Kleppe A, Hveem TS, Carlsen B, Gill S, Löffeler S, Haug ES, Wæhre H, Sooriakumaran P, Danielsen HE (2017) Tumour heterogeneity poses a significant challenge to cancer biomarker research. Br J Cancer 117(3):367–375CrossRef
3.
Robertson NL, Hu Y, Ahmed HU, Freeman A, Barratt D, Emberton M (2014) Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study. Eur Urol 65(3):628–634CrossRef
4.
Wise J (2018) NICE recommends MRI for suspected prostate cancer to reduce biopsies. BMJ 363:k5290CrossRef
5.
Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M, PROMIS study group (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822CrossRef
6.
Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM, PRECISION Study Group Collaborators (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378(19):1767–1777CrossRef
Metadata
Title
Re: Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study
Authors
Joseph M. Norris
Mark Emberton
Clement Orczyk
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 3/2020
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02669-y

Other articles of this Issue 3/2020

World Journal of Urology 3/2020 Go to the issue

Topic Paper

Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review

Topic Paper

Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review

Original Article

Minimally invasive robotic versus conventional open living donor kidney transplantation

Correction

Correction to: Evidence-based approach to active surveillance of prostate cancer

Original Article

Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations

Topic Paper

Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5